Results 171 to 180 of about 40,506 (345)
Adducts of Piperidine, Piperazine, Methylpiperazine, and Morpholine with Bis(β-Ketoenolates) of Nickel(II) [PDF]
G. MARCOTRIGIANO+2 more
openalex +1 more source
Novel Potent and Selective Dopamine D4 Receptor Piperidine Antagonists as Potential Alternatives for the Treatment of Glioblastoma. [PDF]
Matteucci F+16 more
europepmc +1 more source
Work presented here details the design and characterize novel G protein‐gated inwardly rectifying potassium channels (GIRK)1/2 activators. A new 4,4‐difluorocyclohexylpyrazole have been identified that confers improved potency and selectivity for GIRK1/2 versus GIRK1/4.
Sumaiya Nahid+8 more
wiley +1 more source
Driving tert-butyl axial: the surprising cyclopropyl effect. [PDF]
Izzotti AR, Gleason JL.
europepmc +1 more source
Chiron approaches to polyhydroxylated piperidines: promising glycosidase inhibitors
Dilip D. Dhavale+3 more
doaj +1 more source
ROR1 represents a promising target for the development of novel antiproliferative compounds, giving its high expression in different cancer cell lines. The present study describes the workflow leading to the design, synthesis, and characterization of a series of para‐phenylenediamine‐based compounds able to interact with the target kinase, inhibiting ...
Gerardina Smaldone+17 more
wiley +1 more source
2-{<i>N</i>-[ω-(1-Benzylpiperidin-4-yl)alkyl]amino}-6-[(prop-2-yn-1-yl)amino]pyridine-3,5-dicarbonitriles Showing High Affinity for σ<sub>1/2</sub> Receptors. [PDF]
Deuther-Conrad W+7 more
europepmc +1 more source
Tuberculosis (TB) is the leading cause of death among infectious diseases, and new studies focusing new anti‐TB drugs are urgent due to the emergence of drug‐resistant strains. In this regard, homoisoflavones, an underexplored subgroup of flavonoids, were explored for their potential as anti‐TB agents.
Sanderson D. Calixto+12 more
wiley +1 more source
We report the discovery and characterization of a novel series of 4,4‐difluoropiperidine etherbased dopamine D4 receptor antagonists. Structure‐activity relationship studies led to the identification of compound 14a, which displays exceptional binding affinity for the D4 receptor (Ki = 0.3 nM) and remarkable selectivity over other dopamine receptor ...
Saeedeh Saeedi+3 more
wiley +1 more source